[{"AccountsPayableCurrent_0_Q3_USD":2812000.0,"StockIssued1_3_Q3_USD":35000000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_3_Q3_USD":188000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-46330000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-11444000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q3_USD":109276000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":977000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3827000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":35587000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.13,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":33177000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-148000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":4590731.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":6.93,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":169275.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":1514000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":5478728.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":20500000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":8.04,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":7.86,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4209573.0,"PrepaidExpenseCurrent_0_Q3_USD":44000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":539000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":221000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":570427.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":15448301.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-493000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-11196000.0,"ValueAddedTaxReceivable_0_Q3_USD":2900000.0,"PreferredStockValueOutstanding_0_Q3_USD":null,"PaymentsOfStockIssuanceCosts_3_Q3_USD":2917000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-493000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-148000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":106000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":493000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q3_shares":10000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":116545000.0,"BusinessCombinationConsiderationTransferred1_0_Q3_USD":420900000.0,"BusinessCombinationAcquisitionRelatedCosts_3_Q3_USD":2800000.0,"TaxesPayableCurrent_0_Q3_USD":106000.0,"BusinessAcquisitionSharePrice_0_Q3_USD":13.88,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4988000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1332000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-148000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":123530000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":3.02,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":5.7,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":2604000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-13000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-49000.0,"CommonStockNoParValue_0_Q3_USD":0.0001,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-45681000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1332000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":5750000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":3592000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-2591000.0,"NetIncomeLoss_1_Q3_USD":-11296000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-30307000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-21000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":146873000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":126619000.0,"Liabilities_0_Q3_USD":14757000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":156000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":100000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":11836000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6088000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.16,"NetIncomeLoss_3_Q3_USD":-45837000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.28,"Depreciation_3_Q3_USD":15000.0,"CommonStockValue_0_Q3_USD":5000.0,"CommonStockSharesOutstanding_0_Q3_shares":54655376.0,"CommonStockSharesIssued_0_Q3_shares":56455376.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":123530000.0,"AssetsCurrent_0_Q3_USD":126570000.0,"Assets_0_Q3_USD":126619000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11769573.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11769573.0,"AdditionalPaidInCapital_0_Q3_USD":182679000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-147000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":3134000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":21000.0,"ProceedsFromContributedCapital_3_Q3_USD":866000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":49000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":-0.0034,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":-0.009,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":0.0,"SharesIssuedPricePerShare_0_Q3_USD":10.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":null,"ShareBasedCompensation_3_Q3_USD":5123000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":33759000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4953000.0,"ProceedsFromNotesPayable_3_Q3_USD":35000000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingExpenses_3_Q3_USD":45595000.0,"OperatingExpenses_1_Q3_USD":11041000.0,"InterestExpense_3_Q3_USD":625000.0,"InterestExpense_1_Q3_USD":376000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":8705000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":39408236.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":41035055.0,"StockholdersEquity_0_Q3_USD":111862000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-70675000.0,"ValueAddedTaxReceivableCurrent_0_Q3_USD":2996000.0,"WriteOffOfDeferredDebtIssuanceCost_3_Q3_USD":1628000.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200214"}]